Allergy Therapeutics announced the appointments of Anthony Parker and Simon Shen to its Board as Non-Executive Directors effective immediately.
“I would like to welcome Anthony and Simon. Southern Fox and ZQ Capital have been long-standing and supportive shareholders of Allergy over many years, and I have no doubt Anthony and Simon will be invaluable members of the Board, bringing extensive business and innovation sector experience.” said Non-Executive Chairman, Peter Jensen.
Anthony Parker represents Southern Fox Investments Limited and Simon Shen represents ZQ Capital Management Limited acting through its affiliate SkyGem Acquisition Limited.
Allergy Therapeutics plc (LON:AGY) is a market-leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.